App-Quantinova.ai

Long-term Population-based Outcomes of Novel Oral Anticoagulants Compared to Warfarin Among Long-term Anticoagulated Patients: A Propensity Matched Analysis

Heidi T May - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

rivaroxaban

Safety and Cost Effectiveness of Same Day Discharge After Elective Percutaneous Coronary Interventions: A Large Rural Single Center Experience

Rajakrishnan Vijayakrishnan - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Increased Ischemic Heart Disease And Stroke-related Hospitalizations From Cold Temperature in Ontario, Canada: Population-based Study

Qiongsi Li - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Clinically Feasible Electronic Health Record Tool for Stratification of 1- to 3-year Post-myocardial Infarction Risk of Cardiovascular Events: The Intermountain Acute Coronary Syndromes Risk Scores

Joseph B Muhlestein - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Aspirin

The Impact of Atrial Fibrillation Type on the Risk of Thromboembolism, Mortality and Bleeding: A Systematic Review and Meta-analysis

Derek Chew - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Thrombus Aspiration in Primary Percutaneous Coronary Intervention: An Updated Meta-analysis

Francisco Moscoso Costa - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Early and Late Vascular Responses After Stent Implantation in Human Peripheral Artery Disease

Yohei Kobayashi - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Paclitaxel

Efficacy and Safety of a Thinner-strut Silicon Carbide-coated Cobalt Chromium Bare-metal Stent Compared to a Thin-strut Uncoated Cobalt Chromium Bare-metal Stent in Large Vessel Stenting: Insights From Two Prospective Randomised All-comers Trials

Rikke Sorensen - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Risk of Thrombotic Events After Discontinuation of Aspirin in Perioperative Period in Patients with Established or at Risk of Coronary Artery Disease: A Systematic Review and Meta-analysis

Haris Riaz - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Aspirin

Lactate Dehydrogenase Trends Predict Left Ventricular Assist Device Thrombosis

John Ehrlinger - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Efficacy and Safety of Anticoagulation Following Bioprosthetic Aortic Valve Replacement: A Meta-analysis

Muhammad Shahzeb Khan - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Warfarin

Management of Pump Thrombosis in Heartware Hvad Patients

Friedrich Kaufmann - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Elderly Patients Receiving Durable LVAD Support: Insights and Outcomes

Francis D Pagani - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Prevention of HeartMate II Pump Thrombosis - Recommendations and Preliminary Observations From the PREVENT Study

Mary Keebler - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Assessment of Coronary Artery Aneurysms Caused by Kawasaki Disease Using Transluminal Attenuation Gradient Analysis of Coronary CT Angiograms

Olga Shirinsky - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Tadalafil Therapy Improves Endothelial Thrombomodulin in Hypoxemic Patients with Pulmonary Arterial Hypertension Associated with the Eisenmenger Syndrome

Nair Y Maeda - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Chondroitin sulfate

A Novel Model of in vivo Platelet Thrombus Imaging Using CD41-ZsGreen1 Transgenic Rats

Atsuyuki Tomizawa - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Prasugrel

MicroRNA-148a Inhibits Expression of Plasminogen Activator Inhibitor-1: Mechanistic Implications for Obesity-associated Thrombosis

Eric J Devor - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Venous Thromboembolism Recurrence and Bleeding Risk Among Cancer Patients Using a Large Commercial Database

Furaha Kariburyo - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Hydroxyzine

Clinical Significance of Very Late Ischemic and Bleeding Events After Percutaneous Coronary Intervention

Robert W Yeh - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Aspirin

Filters

7277 Abstracts